Recombinant MERS-CoV Spike Protein (aa 1-1297) [His] (VAng-Wyb7329)
Middle East respiratory syndrome coronavirus (NCoV / Novel coronavirus) Spike protein, recombinant protein.
Source
Baculovirus-Insect Cells.
Applications
Used for WB, SDS-PAGE.
Formulation
20 mM Tris, 500 mM Nacl, pH 7.4, 10% glycerol.
Purity
> 85% pure by SDS-PAGE.
Storage
Store at -20°C to -80°C.
Introduction
The MERS (Middle East Respiratory Syndrome) virus is a new type of coronavirus, and most MERS virus infections occur in Saudi Arabia. MERS-CoV was first discovered in Saudi Arabia in September 2012. It is similar to the SARS virus in its clinical symptoms. It was also named SARS-like virus in the early days. It is the sixth known human coronavirus. MERS-CoV is often confused with SARS, but in fact both viruses belong to the coronavirus, but they are genetically distinct and they use different receptors when infecting humans.
Alternative Names
Middle East Respiratory Syndrome Virus; MERS-CoV; Nidovirales; Coronaviridae; Coronavirus; MERS coronavirus
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.